Medigus (MDGS) Trading Below Book Value, An Affiliate Just Made an Accretive Acquisition and the Company is Investing in a New Platform for NFT Digital Creations

Medigus Ltd. (NASDAQ: MDGS), is a technologies company focused on innovative growth partnerships, in advanced medical solutions, digital commerce, and electric vehicle markets.

Current price $1.479/share (as of 10:00 am EDT 10-17-21)

After closing at $1.45/share in the past Friday session, MDGS shares opened at $1.44 and reached a high of $!.49 early today.

When I look at the company stock chart, I note that MDGS shares have crossed their 50 SMA of $1.48 today, and are close to crossing their 20 SMA of $1.51/share. This kind of movement can indicate a potential breakout.

Our considerations on the value of MDGS:

Current market cap of only $34.5M
Shareholder’s equity of $53.9M
Owns investments in public companies with a $31.4M value
Only 23M shares outstanding and in float
H1 2021 net profit $7.9M
No long-term debt

P/E – H1 net profit was $7.9M so full year 2021 net could conservatively be projected at $9.5M resulting in earnings of $.398/share. Using a p/e ratio of 10X we could expect a share price of $3.98.

Price to book – Many value investors consider a stock trading under 3.0X its book value to be a positive metric. In the case of MDGS, the book value is $2.17/share (as of 6-30-21) so using a conservative p/b value of 2.0X we could expect a share price of $4.34/share.

Recent developments

MDGS owns a 33.17% (38.01% on a fully diluted basis) stake in its affiliate, publicly traded Gix Internet (TASE: GIX) and Gix has just completed the acquisition of 70% of Cortex Group, a global marketing technology solutions company. Through Q3 2021 Cortex has reported $26M in revenues and $2.7M in operating profit. Cortex’s financial results will be consolidated with Gix’s financial statements, as of the closing date and are expected to contribute significantly to Gix’s consolidated results for 2021. This is a major accretive acquisition for GIX and may significantly increase the value of the MDGS investment.

The recently announced investment of $400,000 in Safee for a 2.5% stake could be lucrative in the mid to long-term. Traditionally, digital asset management has required a special ‘crypto wallet’ application. To simplify the process and reach a wider audience, Safee has created a simple, engaging, and disruptive way to apply ownership to any personal digital media using NFT technology.

The NFT phenomenon involves ownership, monetization, and the proliferation of digital rights to everyone. Safee’s NFT-based social network platform enables digital creators to take any personal media item (art, photos, videos, music) and turn it into an NFT. If you visit you will be offered a chance to subscribe, join the Safee community, and be updated.

The Traders News Group
original report below

Medigus (MDGS) is Trading Below Book Value, Enters NFT Space and an Acquisition

Good day everyone,

There are a lot of companies that pay lip service to “creating shareholder value,” but every so often I come across one that backs that promise up with actions.

Medigus Ltd. (NASDAQ: MDGS), is a technologies company that is focused on innovative growth partnerships, in advanced medical solutions, digital commerce, and electric vehicle markets.

Current price $1.45/share (as of market close 10-15-21)

In 2019 MDGS was a company with two technologies that were dynamic and innovative but weren’t commercially successful. That is when the company began the transformation to its current business model that has now come to fruition and is still growing.

I talked about MDGS a month ago. I want to update you as to what has been happening at the company because it, once again, seems positioned for a near term gain in value. There has been a consolidation in the company’s market value, news from some of the partners it has invested in, and not least of all, a new, informative website. MDGS has 23M shares outstanding and in the float.

H1 2021 Results: (for the six months ending June 30th)
Revenues $2.4M

Net Profit $7.9M (the MDGS market value is only $34.5M)
Cash & Equiv. $29.6M

I want to further discuss that MDGS transformation we discussed last month, but first I want to point out a few reasons I think the MDGS value could rise significantly in the near-term. I looked at the company 6-K for the period ending June 30, 2021, filed on September 20, 2021. I assume any material changes before the filing date would have been reported. This metric stood out!

MDGS reports shareholders equity of $53.9M which represents a book value of $2.17/share. The current market cap/share price is 34% below this level.

The investments made by MDGS during their company transition have been lucrative. Not all of them yet, but a few are contributing, not necessarily to the top line, but nicely to the company’s bottom line. An important part of your due diligence would be to familiarize yourself with these companies MDGS has invested in.

ScoutCam Inc. is a public company (OTCQB: SCTC), an entity in which MDGS owns 27.76%. SCTC produces the smallest cameras produced in the world (down to 1mm diameter including illumination), ScoutCam devices are used across the medical, aerospace, industrial, research and defense industries. SCTC is currently valued at $56.8M making the MDGS investment worth $15.7M.

Gix Internet is a public company (TASE: GIX), in which Medigus owns 33.17% on a fully diluted basis. GIX is a global marketing technology solutions company for online performance-based-marketing. GIX is currently valued at $55.6M making the MDGS investment worth $18.4M. The company just announced that Gix Internet’s subsidiary, Gix Media completed the acquisition of 70% of Cortex Group, an innovative media-tech company that has developed expertise in turning original content into a profit center through user traffic acquisition. Cortex has H1 2021 revenues over $13M and is profitable.

It is worthy to note that the current combined value of the MDGS investment in these two public companies ($34.1M) is near the current market value of MDGS of $34.5M.

Eventer Technologies Ltd. Is a private company 47.69% owned by MDGS. Eventer operates an online event management plugin and ticketing platform for the creation, management, promotion, ticketing, and billing of live and online events. Eventer has filed its first public prospectus draft for an IPO of its shares on the Tel Aviv Stock Exchange (TASE).

Polyrizon Ltd. is a privately company in which Medigus owns 35.86%. Polyrizon’s technology is comprised of a bio-gel that is applied topically designed to safely prevent allergens and virus intrusion through the upper airways and eye cavities.

Jeffs Brands Ltd. Is a private company and along with its subsidiaries Smart Repair Pro, Purex and Top Rank, is 50.03% owned by Medigus. Jeff’s Brands owns six branded products that it globally sells within their Fulfillment by Amazon shops. Jeff Brands just signed a non-binding collaboration agreement with iFulfillYou LLC, a U.S.-based warehousing logistics services company under which the parties intend to collaborate for the establishment of logistics warehouses in the U.S.

Charging Robotics is a wholly owned subsidiary of Medigus developing a robotic platform for charging vehicles in a wireless and automatic manner without plugs or cables. No more searching for a parking spot with a charger.

Revoltz is a privately held company that is 19.9% owned by MDGS (through Charging Robotics). The company develops electric micro-mobility vehicles and has completed a prototype of Model One, its micro mobility vehicle for last mile and food delivery.

The companies above, that represent MDGS investments, are more fully described on the company website.

Now the company has announced its intent to invest $400K for a 2.5% stake in Safee, a Non-Fungible Token (NFT) technology company. Safee’s social network will allow creators and collectors to easily trade digital goods. It will enable regular people and digital creators alike to monetize their creations in the digital world.

The Medigus Ultrasonic Surgical Endostapler, or MUSE™ system, is an endoscopic device to deliver a more patient-friendly option for Transoral Fundoplication (TF), the procedure is intended to treat the leading cause of GERD (gastroesophageal reflux disease). MDGS developed this product before their transformation that began in 2019 and is currently focused on a licensing or sale agreement for the product.

Stay tuned for more information on MDGS.
The Traders News Group



Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone. Please see our cookie policy below.
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, the small cap stock reports you requested, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act.
Online Privacy Policy Policy
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.
Please Note: TNS LLC and its employees are not a registered investment advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.
Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The owners and operators of this website have been compensated twelve thousand five hundred dollars cash via bank wire for our distributed opinions this week on mdgs. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.